IPCA LABORATORIES LIMITED

IPCA Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India. The company is primarily engaged in the manufacturing and marketing of a wide range of pharmaceutical formulations and active pharmaceutical ingredients APIs. IPCA is recognized as one of the world's largest manufacturers of APIs for various therapeutic segments. It has a significant global presence with operations spanning multiple countries and is known for its strong research and development capabilities and commitment to quality.

The company is a manufacturer.

IPCA Laboratories Limited manufactures and sells a wide range of pharmaceutical products. These primarily include:

Active Pharmaceutical Ingredients (APIs) such as Hydroxychloroquine Sulfate, Chloroquine Phosphate, Atenolol, Furosemide, and Metoprolol Succinate.

Finished Dosage Forms (Formulations) in various forms including tablets, capsules, injections, syrups, suspensions, ointments, and creams.

Their formulations cater to a broad spectrum of therapeutic segments:

Anti-malarial

Pain Management

Cardiology

Gastroenterology

Anti-infective

Dermatology

Ophthalmology

Nutraceuticals

Anti-diabetic

Respiratory

Urology

Central Nervous System (CNS)

Some of their key brands in these segments are:

Lariago (Anti-malarial)

Zerodol (Pain Management)

Perizone (Cardiology)

Rantac (Gastroenterology)

Teneliglim (Anti-diabetic)

Cipcal (Nutraceutical)